Profile data is unavailable for this security.
About the company
Epigenomics AG is a Germany-based molecular diagnostics company focused on blood-based detection, prognosis and monitoring of cancers using deoxyribonucleic acid (DNA) methylation technology. It develops and commercializes blood-based diagnostic products across multiple cancer indications. The Company's main product is Epi proColon, a blood test for colorectal cancer screening. Along with the blood-based tests the Company offers services related to research, product development, regulatory approval and manufacturing of in-vitro diagnostic (IVD) products. It also offers Epi proLung, a blood-based test that detects the presence of lung cancer in blood plasma. The Company is present in Europe and the United States.
- Revenue in EUR (TTM)448.00k
- Net income in EUR-16.29m
- Incorporated2000
- Employees18.00
- LocationEpigenomics AGGeneststrasse 5BERLIN 10829GermanyDEU
- Phone+49 30243450
- Fax+49 3 024345555
- Websitehttps://www.epigenomics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
European Institute of Science AB | 59.12k | -237.47k | 121.06k | 2.00 | -- | 1.35 | -- | 2.05 | -4.23 | -4.23 | 1.05 | 1.93 | 0.2438 | 1.24 | 9.47 | 343,435.00 | -97.95 | -93.04 | -105.15 | -103.14 | 59.32 | 66.99 | -401.71 | -518.86 | 5.70 | -- | 0.00 | -- | 13.66 | 8.54 | 0.3974 | -- | -- | -- |
Paion AG | -100.00bn | -100.00bn | 158.37k | 64.00 | -- | -- | -- | -- | -- | -- | -- | -0.4074 | -- | -- | -- | -- | -- | -24.86 | -- | -34.32 | -- | -- | -- | -52.40 | 0.5078 | -- | 1.17 | -- | 366.42 | 41.74 | 97.34 | -- | 129.37 | -- |
Epigenomics AG | 448.00k | -16.29m | 500.59k | 18.00 | -- | 0.2557 | -- | 1.12 | -19.49 | -19.49 | 0.536 | 2.24 | 0.0361 | 2.73 | 3.34 | 13,176.47 | -131.18 | -65.64 | -167.31 | -83.85 | 76.56 | 89.26 | -3,636.16 | -548.19 | 1.93 | -- | 0.1572 | -- | -92.18 | -23.61 | -395.22 | -- | 44.06 | -- |
Theravet SA | -100.00bn | -100.00bn | 856.29k | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Diagonal Bio AB | 1.98k | -944.47k | 958.56k | 4.00 | -- | 0.1004 | -- | 484.25 | -0.1772 | -0.1772 | 0.0004 | 0.2768 | 0.0008 | -- | 2.00 | 4,600.00 | -36.58 | -- | -47.91 | -- | -35,765.22 | -- | -47,713.04 | -- | 0.2476 | -27.65 | 0.00 | -- | -88.67 | -- | 27.75 | -- | -- | -- |
2cureX AB | 13.34k | -2.80m | 969.59k | 14.00 | -- | 0.9328 | -- | 72.68 | -1.85 | -1.85 | 0.0088 | 0.6861 | 0.0049 | -- | 0.1147 | 11,071.43 | -101.72 | -38.93 | -117.90 | -44.42 | -7,782.58 | -22,717.96 | -20,979.36 | -39,378.78 | -- | -46.38 | 0.00 | -- | 72.22 | -- | -9.23 | -- | -57.30 | -- |
Carbiotix AB (publ) | 146.35k | -1.25m | 1.03m | 10.00 | -- | 0.4008 | -- | 7.07 | -0.2357 | -0.2357 | 0.0196 | 0.1492 | 0.0658 | -- | 3.43 | 170,052.00 | -56.32 | -49.38 | -62.10 | -55.50 | 201.79 | 574.69 | -855.62 | -1,828.86 | -- | -45.74 | 0.00 | -- | 259.56 | -12.04 | -10.02 | -- | 13.64 | -- |
Asarina Pharma AB (publ) | 0.00 | -1.10m | 1.17m | 2.00 | -- | 8.24 | -- | -- | -0.5666 | -0.5666 | 0.00 | 0.0728 | 0.00 | -- | -- | 0.00 | -111.87 | -61.25 | -157.85 | -71.89 | -- | -- | -- | -- | -- | -- | 0.3775 | -- | -- | -- | 3.43 | -- | -- | -- |
Oxurion NV | 263.00k | -18.97m | 1.23m | 20.00 | -- | -- | -- | 4.67 | -0.023 | -0.023 | 0.0002 | -0.0038 | 0.0284 | 63.60 | 0.1253 | 13,150.00 | -204.59 | -84.30 | -- | -118.70 | 39.54 | 48.90 | -7,212.55 | -2,008.99 | 0.1398 | -1.75 | -- | -- | -55.80 | -45.20 | 40.13 | -- | -65.17 | -- |
Gabather AB | 0.00 | -911.08k | 1.23m | -- | -- | -- | -- | -- | -0.6814 | -0.6814 | 0.00 | -0.1489 | 0.00 | -- | -- | -- | -144.39 | -56.57 | -1,110.23 | -67.36 | -- | -- | -- | -17,298,800.00 | -- | -- | -- | -- | -- | -- | -10.40 | -- | -- | -- |
Ovoca Bio PLC | 0.00 | -5.10m | 1.31m | 5.00 | -- | 0.5251 | -- | -- | -0.0527 | -0.0485 | 0.00 | 0.0238 | 0.00 | -- | -- | 0.00 | -79.30 | -25.19 | -94.61 | -27.65 | -- | -- | -- | -- | 6.55 | -1,019.80 | 0.00 | -- | -- | -- | 9.05 | -- | -- | -- |
Amniotics AB (publ) | 0.00 | -2.66m | 1.39m | 9.00 | -- | 1.03 | -- | -- | -0.0374 | -0.0374 | 0.00 | 0.0057 | 0.00 | -- | -- | 0.00 | -112.25 | -101.09 | -362.62 | -149.91 | -- | -- | -- | -- | 1.12 | -16.17 | 0.00 | -- | -- | -- | 35.75 | -- | -- | -- |
Lidds AB | 0.00 | -2.63m | 1.64m | 2.00 | -- | 1.88 | -- | -- | -0.5546 | -0.5546 | 0.00 | 0.0746 | 0.00 | -- | -- | 0.00 | -95.41 | -46.33 | -110.09 | -51.61 | -- | -1,934.24 | -- | -3,076.68 | -- | -- | 0.0812 | -- | -100.00 | -- | -9.08 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
FPS Verm�gensverwaltung GmbHas of 31 Dec 2023 | 29.00 | 0.02% |